tirzepatide and glaucoma Ocular Hypertension: Diagnosis Treatment Tirzepatide Associated with Lower POAG,
Description
Because of this, more studies were done, and the FDA approved the drug for weight management
Also included are specific care and treatment needs of pregnant women and those who are hospitalized
February 25, 2026: Zepbound Label Updated with Warning of Severe Gastrointestinal Issues The FDA has posted an updated Zepbound warning label, which includes reports of gastrointestinal issues that patients claim they experienced after Zepbound reached the market
[DOI] [PubMed] [Google Scholar] 495.Pouwels, S
